objectives: evidence on the effects of the SARS-CoV-2 omicron variant on vaccinated and unvaccinated pregnant women is sparse. this study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the omicron wave in Italy, according to their vaccine protection. methods: this national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 january and 31 may, 2022. women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). a multivariable logistic regression model evaluated the association between vaccine protection and disease severity. maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. results: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. a higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in asian countries (OR, 3.05; 95% CI, 1.23–7.56). the percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). discussion: although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended.

Corsi Decenti, E., Antonio Salvatore, M., Mandolini, D., Donati, S., Alberi, I., Camandona, F., et al. (2023). Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system. CLINICAL MICROBIOLOGY AND INFECTION, 29(6), 772-780 [10.1016/j.cmi.2023.01.013].

Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system

Daniele Farsetti;
2023-01-01

Abstract

objectives: evidence on the effects of the SARS-CoV-2 omicron variant on vaccinated and unvaccinated pregnant women is sparse. this study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the omicron wave in Italy, according to their vaccine protection. methods: this national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 january and 31 may, 2022. women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). a multivariable logistic regression model evaluated the association between vaccine protection and disease severity. maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. results: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. a higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in asian countries (OR, 3.05; 95% CI, 1.23–7.56). the percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). discussion: although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended.
2023
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MEDS-21/A - Ginecologia e ostetricia
English
COVID-19
Omicron wave
Pregnant women
SARS-CoV-2
Vaccination
Vaccine protection against severe disease
Corsi Decenti, E., Antonio Salvatore, M., Mandolini, D., Donati, S., Alberi, I., Camandona, F., et al. (2023). Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system. CLINICAL MICROBIOLOGY AND INFECTION, 29(6), 772-780 [10.1016/j.cmi.2023.01.013].
Corsi Decenti, E; Antonio Salvatore, M; Mandolini, D; Donati, S; Alberi, I; Camandona, F; Casucci, P; Cetin, I; Ciavattini, A; Damiani, F; Di Sebastia...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Corsi Decenti 2023 Clin Microbiol Infect.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 305.04 kB
Formato Adobe PDF
305.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/395487
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact